RACHEL ADKINS: Open Payments
NPI 1225548589 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 16 payments from 13 companies in 2025. Trend: 2023 $1,304 · 2024 $488 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $205 |
| Lilly USA, LLC | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Sequel Med Tech, LLC | 1 | $29 |
| Exact Sciences Corporation | 1 | $27 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Amgen Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| CeQur Corporation | 1 | $17 |
Products named: REZDIFFRA, ZEPBOUND, Kerendia, TWIIST, Cologuard Collection Kit, CRYSVITA, TEPEZZA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
